ACUR
Acura Pharmaceuticals
ACUR
ACUR
Delisted
ACUR was delisted on the 22nd of February, 2017.
33 hedge funds and large institutions have $12.6M invested in Acura Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
Holders
33
Holding in Top 10
1
Calls
$10K
Puts
$14K
Top Buyers
| 1 | +$115K | |
| 2 | +$27.6K | |
| 3 | +$14K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$13K |
| 5 |
AP
Atwood & Palmer
Kansas City,
Missouri
|
+$6K |
Top Sellers
| 1 | -$131K | |
| 2 | -$95K | |
| 3 | -$42.7K | |
| 4 |
SIM
Spark Investment Management
New York
|
-$42K |
| 5 |
Morgan Stanley
New York
|
-$36.6K |